rs4664475

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001164508.2(NEB):​c.21585A>G​(p.Thr7195Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.603 in 1,611,460 control chromosomes in the GnomAD database, including 297,798 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.56 ( 24444 hom., cov: 31)
Exomes 𝑓: 0.61 ( 273354 hom. )

Consequence

NEB
NM_001164508.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -3.29
Variant links:
Genes affected
NEB (HGNC:7720): (nebulin) This gene encodes nebulin, a giant protein component of the cytoskeletal matrix that coexists with the thick and thin filaments within the sarcomeres of skeletal muscle. In most vertebrates, nebulin accounts for 3 to 4% of the total myofibrillar protein. The encoded protein contains approximately 30-amino acid long modules that can be classified into 7 types and other repeated modules. Protein isoform sizes vary from 600 to 800 kD due to alternative splicing that is tissue-, species-,and developmental stage-specific. Of the 183 exons in the nebulin gene, at least 43 are alternatively spliced, although exons 143 and 144 are not found in the same transcript. Of the several thousand transcript variants predicted for nebulin, the RefSeq Project has decided to create three representative RefSeq records. Mutations in this gene are associated with recessive nemaline myopathy. [provided by RefSeq, Sep 2009]
RIF1 (HGNC:23207): (replication timing regulatory factor 1) This gene encodes a protein that shares homology with the yeast teleomere binding protein, Rap1 interacting factor 1. This protein localizes to aberrant telomeres may be involved in DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-151531039-T-C is Benign according to our data. Variant chr2-151531039-T-C is described in ClinVar as [Benign]. Clinvar id is 95114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-151531039-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.29 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBNM_001164507.2 linkc.21585A>G p.Thr7195Thr synonymous_variant Exon 145 of 182 ENST00000427231.7 NP_001157979.2
NEBNM_001164508.2 linkc.21585A>G p.Thr7195Thr synonymous_variant Exon 145 of 182 ENST00000397345.8 NP_001157980.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBENST00000397345.8 linkc.21585A>G p.Thr7195Thr synonymous_variant Exon 145 of 182 5 NM_001164508.2 ENSP00000380505.3 P20929-2
NEBENST00000427231.7 linkc.21585A>G p.Thr7195Thr synonymous_variant Exon 145 of 182 5 NM_001164507.2 ENSP00000416578.2 P20929-3

Frequencies

GnomAD3 genomes
AF:
0.555
AC:
84284
AN:
151820
Hom.:
24422
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.389
Gnomad AMI
AF:
0.509
Gnomad AMR
AF:
0.681
Gnomad ASJ
AF:
0.510
Gnomad EAS
AF:
0.582
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.644
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.625
Gnomad OTH
AF:
0.565
GnomAD3 exomes
AF:
0.589
AC:
145970
AN:
247906
Hom.:
44307
AF XY:
0.579
AC XY:
77812
AN XY:
134422
show subpopulations
Gnomad AFR exome
AF:
0.389
Gnomad AMR exome
AF:
0.724
Gnomad ASJ exome
AF:
0.523
Gnomad EAS exome
AF:
0.578
Gnomad SAS exome
AF:
0.409
Gnomad FIN exome
AF:
0.639
Gnomad NFE exome
AF:
0.620
Gnomad OTH exome
AF:
0.610
GnomAD4 exome
AF:
0.608
AC:
886922
AN:
1459522
Hom.:
273354
Cov.:
39
AF XY:
0.601
AC XY:
436676
AN XY:
726030
show subpopulations
Gnomad4 AFR exome
AF:
0.387
Gnomad4 AMR exome
AF:
0.716
Gnomad4 ASJ exome
AF:
0.520
Gnomad4 EAS exome
AF:
0.626
Gnomad4 SAS exome
AF:
0.410
Gnomad4 FIN exome
AF:
0.641
Gnomad4 NFE exome
AF:
0.626
Gnomad4 OTH exome
AF:
0.590
GnomAD4 genome
AF:
0.555
AC:
84339
AN:
151938
Hom.:
24444
Cov.:
31
AF XY:
0.557
AC XY:
41374
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.390
Gnomad4 AMR
AF:
0.682
Gnomad4 ASJ
AF:
0.510
Gnomad4 EAS
AF:
0.582
Gnomad4 SAS
AF:
0.404
Gnomad4 FIN
AF:
0.644
Gnomad4 NFE
AF:
0.625
Gnomad4 OTH
AF:
0.558
Alfa
AF:
0.604
Hom.:
35137
Bravo
AF:
0.556
Asia WGS
AF:
0.451
AC:
1572
AN:
3478
EpiCase
AF:
0.602
EpiControl
AF:
0.612

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Nov 03, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 05, 2013
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 26, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This is a RefSeq error. The reference base (c.21690A) is the minor allele. This allele (A) has been identified in 38% (3158/8354) of European American chromosom es and 59% (2374/4046) of African American chromosomes by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs4664475) and thus meets criteria to be classified as benign. -

Nemaline myopathy 2 Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 27, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: The NEB c.21690A>G (p.Thr7230Thr) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a polymorphism outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. This variant was found in 69172/118646 control chromosomes (20606 homozygotes) at a frequency of 0.5830116, which is approximately 165 times the estimated maximal expected allele frequency of a pathogenic NEB variant (0.0035355), evidence that this variant is a benign polymorphism. Multiple clinical diagnostic laboratories cite the variant as "benign." Taken together, this variant is classified as benign. -

Feb 28, 2019
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Arthrogryposis multiplex congenita 6 Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.094
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4664475; hg19: chr2-152387553; COSMIC: COSV51424628; COSMIC: COSV51424628; API